HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: T500011-MCP200v1 4/10/1626    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Glossary Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Knuesel, M. Articles by Liu, X. Search for Related Content PubMed PubMed Citation Articles by Knuesel, M. Articles by Liu, X. Social Bookmarking                      What's this?

Molecular & Cellular Proteomics 4:1626-1636, 2005.
© 2005 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Technology

A Method of Mapping Protein Sumoylation Sites by Mass Spectrometry Using a Modified Small Ubiquitin-like Modifier 1 (SUMO-1) and a Computational Program^*,S

Matthew Knuesel, Hiu Tom Cheung^,, Micah Hamady^¶, Kristen K. B. Barthel^,|| and Xuedong Liu^,**

From the Departments of Chemistry and Biochemistry and ^¶ Computer Science, University of Colorado, Boulder, Colorado 80309

Post-translational modification by small ubiquitin-like modifier 1 (SUMO-1) is a highly conserved process from yeast to humans and plays important regulatory roles in many cellular processes. Sumoylation occurs at certain internal lysine residues of target proteins via an isopeptide bond linkage. Unlike ubiquitin whose carboxyl-terminal sequence is RGG, the tripeptide at the carboxyl terminus of SUMO is TGG. The presence of the arginine residue at the carboxyl terminus of ubiquitin allows tryptic digestion of ubiquitin conjugates to yield a signature peptide containing a diglycine remnant attached to the target lysine residue and rapid identification of the ubiquitination site by mass spectrometry. The absence of lysine or arginine residues in the carboxyl terminus of mammalian SUMO makes it difficult to apply this approach to mapping sumoylation sites. We performed Arg scanning mutagenesis by systematically substituting amino acid residues surrounding the diglycine motif and found that a SUMO variant terminated with RGG can be conjugated efficiently to its target protein under normal sumoylation conditions. We developed a Programmed Data Acquisition (PDA) mass spectrometric approach to map target sumoylation sites using this SUMO variant. A web-based computational program designed for efficient identification of the modified peptides is described.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H.-H. Hsiao, E. Meulmeester, B. T. C. Frank, F. Melchior, and H. Urlaub "ChopNSpice," a Mass Spectrometric Approach That Allows Identification of Endogenous Small Ubiquitin-like Modifier-conjugated Peptides Mol. Cell. Proteomics, December 1, 2009; 8(12): 2664 - 2675. [Abstract] [Full Text] [PDF]

				S. Okada, M. Nagabuchi, Y. Takamura, T. Nakagawa, K. Shinmyozu, J.-i. Nakayama, and K. Tanaka Reconstitution of Arabidopsis thaliana SUMO Pathways in E. coli: Functional Evaluation of SUMO Machinery Proteins and Mapping of SUMOylation Sites by Mass Spectrometry Plant Cell Physiol., June 1, 2009; 50(6): 1049 - 1061. [Abstract] [Full Text] [PDF]

				K. Schwamborn, P. Knipscheer, E. van Dijk, W. J. van Dijk, T. K. Sixma, R. H. Meloen, and J. P.M. Langedijk SUMO Assay with Peptide Arrays on Solid Support: Insights into SUMO Target Sites J. Biochem., July 1, 2008; 144(1): 39 - 49. [Abstract] [Full Text] [PDF]

				I. Matic, M. van Hagen, J. Schimmel, B. Macek, S. C. Ogg, M. H. Tatham, R. T. Hay, A. I. Lamond, M. Mann, and A. C. O. Vertegaal In Vivo Identification of Human Small Ubiquitin-like Modifier Polymerization Sites by High Accuracy Mass Spectrometry and an in Vitro to in Vivo Strategy Mol. Cell. Proteomics, January 1, 2008; 7(1): 132 - 144. [Abstract] [Full Text] [PDF]